106 related articles for article (PubMed ID: 29958885)
1. SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1/Prx III axis.
Huynh DL; Zhang JJ; Chandimali N; Ghosh M; Gera M; Kim N; Park YH; Kwon T; Jeong DK
Biochem Biophys Res Commun; 2018 Sep; 503(4):2248-2254. PubMed ID: 29958885
[TBL] [Abstract][Full Text] [Related]
2. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
[TBL] [Abstract][Full Text] [Related]
3. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
[TBL] [Abstract][Full Text] [Related]
4. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
[TBL] [Abstract][Full Text] [Related]
5. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.
Li XY; Wu HY; Mao XF; Jiang LX; Wang YX
Biochem Biophys Res Commun; 2017 Oct; 492(1):48-54. PubMed ID: 28807830
[TBL] [Abstract][Full Text] [Related]
6. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
7. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
[TBL] [Abstract][Full Text] [Related]
8. SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features.
Vienot A; Monnien F; Truntzer C; Mougey V; Bouard A; Pallandre JR; Molimard C; Loyon R; Asgarov K; Averous G; Ghiringhelli F; Bibeau F; Peixoto P; Borg C
Mol Oncol; 2023 Jul; 17(7):1356-1378. PubMed ID: 36587397
[TBL] [Abstract][Full Text] [Related]
9. CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Li K; Xu B; Xu G; Liu R
Tumour Biol; 2016 Jan; 37(1):419-24. PubMed ID: 26219899
[TBL] [Abstract][Full Text] [Related]
10. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
11. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
12. The roles of FOXM1 in pancreatic stem cells and carcinogenesis.
Quan M; Wang P; Cui J; Gao Y; Xie K
Mol Cancer; 2013 Dec; 12():159. PubMed ID: 24325450
[TBL] [Abstract][Full Text] [Related]
13. Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer.
Zhang J; Niu Y; Huang C
Recent Pat Anticancer Drug Discov; 2017; 12(3):247-259. PubMed ID: 28440206
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
[TBL] [Abstract][Full Text] [Related]
15. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1.
Yu CP; Yu S; Shi L; Wang S; Li ZX; Wang YH; Sun CJ; Liang J
Mol Med Rep; 2017 Oct; 16(4):5181-5188. PubMed ID: 28849004
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma.
Träger MM; Dhayat SA
Int J Cancer; 2017 Jul; 141(1):24-32. PubMed ID: 28133736
[TBL] [Abstract][Full Text] [Related]
19. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
20. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]